Last 12 months
Inside the activity.
6 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 1 | 0 |
| Feb 2026 | 2 | 0 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 2 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 28, 2008 Filed Sep 2, 2008 23:51 UTC |
Schumacher Laura JExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 2,197 | $0.00 Strike: $58.16 | $0.00 |
DisclosureSEC source: 0001104659-08-056454 · a4.xml · derivative · entry 4 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 2,197 shares Expires 2009-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 28, 2008 Filed Sep 2, 2008 23:51 UTC |
Schumacher Laura JExecutive Vice President
|
SaleCommon shares without par value | 2,197 | $58.24 | $127,953.28 |
DisclosureSEC source: 0001104659-08-056454 · a4.xml · nonDerivative · entry 2 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,402 Read SEC document |
| August 28, 2008 Filed Sep 2, 2008 23:51 UTC |
Schumacher Laura JExecutive Vice President
|
Exercise / conversionCommon shares without par value | 2,197 | $58.16 | $127,777.52 |
DisclosureSEC source: 0001104659-08-056454 · a4.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,599 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 28, 2008 Filed Sep 2, 2008 23:53 UTC |
LIEPMANN HOLGER AExecutive Vice President
|
GrantOption (right to buy) · Derivative | 10,630 | $0.00 Strike: $57.72 | $0.00 |
DisclosureSEC source: 0001104659-08-056455 · a4.xml · derivative · entry 10 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,630 Underlying: Common shares · 10,630 shares Expires 2011-02-08 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 28, 2008 Filed Sep 2, 2008 23:53 UTC |
LIEPMANN HOLGER AExecutive Vice President
|
GrantOption (right to buy) · Derivative | 2,051 | $0.00 Strike: $57.72 | $0.00 |
DisclosureSEC source: 0001104659-08-056455 · a4.xml · derivative · entry 9 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,051 Underlying: Common shares · 2,051 shares Expires 2011-07-08 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 28, 2008 Filed Sep 2, 2008 23:53 UTC |
LIEPMANN HOLGER AExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 12,200 | $0.00 Strike: $45.45 | $0.00 |
DisclosureSEC source: 0001104659-08-056455 · a4.xml · derivative · entry 8 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,028 Underlying: Common shares · 12,200 shares Expires 2011-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 28, 2008 Filed Sep 2, 2008 23:53 UTC |
LIEPMANN HOLGER AExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 2,378 | $0.00 Strike: $44.61 | $0.00 |
DisclosureSEC source: 0001104659-08-056455 · a4.xml · derivative · entry 7 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 2,378 shares Expires 2011-07-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 28, 2008 Filed Sep 2, 2008 23:53 UTC |
LIEPMANN HOLGER AExecutive Vice President
|
Tax withholdingCommon shares without par value | 12,681 | $57.72 | $731,947.32 |
DisclosureSEC source: 0001104659-08-056455 · a4.xml · nonDerivative · entry 3 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,775 Read SEC document |
| August 28, 2008 Filed Sep 2, 2008 23:53 UTC |
LIEPMANN HOLGER AExecutive Vice President
|
Exercise / conversionCommon shares without par value | 12,200 | $45.45 | $554,475.36 |
DisclosureSEC source: 0001104659-08-056455 · a4.xml · nonDerivative · entry 2 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,456 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 28, 2008 Filed Sep 2, 2008 23:53 UTC |
LIEPMANN HOLGER AExecutive Vice President
|
Exercise / conversionCommon shares without par value | 2,378 | $44.61 | $106,088.29 |
DisclosureSEC source: 0001104659-08-056455 · a4.xml · nonDerivative · entry 1 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,256 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 27, 2008 Filed Aug 28, 2008 21:08 UTC |
Szela Mary TSenior Vice President
|
Tax withholdingCommon shares without par value | 1,026 | $57.57 | $59,066.82 |
DisclosureSEC source: 0001104659-08-055817 · a4.xml · nonDerivative · entry 5 Szela Mary T · CIK 0001410289 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,213 Read SEC document |
| August 27, 2008 Filed Aug 28, 2008 21:10 UTC |
Tyree James LExecutive Vice President
|
Tax withholdingCommon shares without par value | 711 | $57.57 | $40,932.27 |
DisclosureSEC source: 0001104659-08-055818 · a4.xml · nonDerivative · entry 3 Tyree James L · CIK 0001324991 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,247 Read SEC document |
| August 26, 2008 Filed Aug 28, 2008 21:08 UTC |
Szela Mary TSenior Vice President
|
GrantOption (right to buy) · Derivative | 423 | $0.00 Strike: $57.76 | $0.00 |
DisclosureSEC source: 0001104659-08-055817 · a4.xml · derivative · entry 12 Szela Mary T · CIK 0001410289 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 423 Underlying: Common Shares · 423 shares Expires 2011-02-08 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 26, 2008 Filed Aug 28, 2008 21:08 UTC |
Szela Mary TSenior Vice President
|
GrantOption (right to buy) · Derivative | 1,743 | $0.00 Strike: $57.76 | $0.00 |
DisclosureSEC source: 0001104659-08-055817 · a4.xml · derivative · entry 11 Szela Mary T · CIK 0001410289 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,743 Underlying: Common Shares · 1,743 shares Expires 2014-02-19 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 26, 2008 Filed Aug 28, 2008 21:08 UTC |
Szela Mary TSenior Vice President
|
GrantOption (right to buy) · Derivative | 1,404 | $0.00 Strike: $57.76 | $0.00 |
DisclosureSEC source: 0001104659-08-055817 · a4.xml · derivative · entry 10 Szela Mary T · CIK 0001410289 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,404 Underlying: Common Shares · 1,404 shares Expires 2010-02-10 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 26, 2008 Filed Aug 28, 2008 21:08 UTC |
Szela Mary TSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 538 | $0.00 Strike: $45.45 | $0.00 |
DisclosureSEC source: 0001104659-08-055817 · a4.xml · derivative · entry 9 Szela Mary T · CIK 0001410289 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,919 Underlying: Common Shares · 538 shares Expires 2011-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 26, 2008 Filed Aug 28, 2008 21:08 UTC |
Szela Mary TSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 2,454 | $0.00 Strike: $41.03 | $0.00 |
DisclosureSEC source: 0001104659-08-055817 · a4.xml · derivative · entry 8 Szela Mary T · CIK 0001410289 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 2,454 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 26, 2008 Filed Aug 28, 2008 21:08 UTC |
Szela Mary TSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 2,488 | $0.00 Strike: $32.61 | $0.00 |
DisclosureSEC source: 0001104659-08-055817 · a4.xml · derivative · entry 7 Szela Mary T · CIK 0001410289 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 2,488 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 26, 2008 Filed Aug 28, 2008 21:08 UTC |
Szela Mary TSenior Vice President
|
Tax withholdingCommon shares without par value | 3,570 | $57.76 | $206,203.20 |
DisclosureSEC source: 0001104659-08-055817 · a4.xml · nonDerivative · entry 4 Szela Mary T · CIK 0001410289 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,239 Read SEC document |
| August 26, 2008 Filed Aug 28, 2008 21:08 UTC |
Szela Mary TSenior Vice President
|
Exercise / conversionCommon shares without par value | 538 | $45.45 | $24,451.45 |
DisclosureSEC source: 0001104659-08-055817 · a4.xml · nonDerivative · entry 3 Szela Mary T · CIK 0001410289 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,809 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 26, 2008 Filed Aug 28, 2008 21:08 UTC |
Szela Mary TSenior Vice President
|
Exercise / conversionCommon shares without par value | 2,454 | $41.03 | $100,691.79 |
DisclosureSEC source: 0001104659-08-055817 · a4.xml · nonDerivative · entry 2 Szela Mary T · CIK 0001410289 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,271 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 26, 2008 Filed Aug 28, 2008 21:08 UTC |
Szela Mary TSenior Vice President
|
Exercise / conversionCommon shares without par value | 2,488 | $32.61 | $81,136.42 |
DisclosureSEC source: 0001104659-08-055817 · a4.xml · nonDerivative · entry 1 Szela Mary T · CIK 0001410289 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,817 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 26, 2008 Filed Aug 28, 2008 21:10 UTC |
Tyree James LExecutive Vice President
|
GrantOption (right to buy) · Derivative | 4,145 | $0.00 Strike: $57.76 | $0.00 |
DisclosureSEC source: 0001104659-08-055818 · a4.xml · derivative · entry 6 Tyree James L · CIK 0001324991 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,145 Underlying: Common shares · 4,145 shares Expires 2011-02-08 F2 · security: Employee stock option, including a replacement option feature, granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 26, 2008 Filed Aug 28, 2008 21:10 UTC |
Tyree James LExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 4,759 | $0.00 Strike: $45.45 | $0.00 |
DisclosureSEC source: 0001104659-08-055818 · a4.xml · derivative · entry 5 Tyree James L · CIK 0001324991 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,843 Underlying: Common shares · 4,759 shares Expires 2011-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option, including a replacement option feature, granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 26, 2008 Filed Aug 28, 2008 21:10 UTC |
Tyree James LExecutive Vice President
|
Tax withholdingCommon shares without par value | 4,145 | $57.76 | $239,415.20 |
DisclosureSEC source: 0001104659-08-055818 · a4.xml · nonDerivative · entry 2 Tyree James L · CIK 0001324991 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,958 Read SEC document |
| August 26, 2008 Filed Aug 28, 2008 21:10 UTC |
Tyree James LExecutive Vice President
|
Exercise / conversionCommon shares without par value | 4,759 | $45.45 | $216,290.84 |
DisclosureSEC source: 0001104659-08-055818 · a4.xml · nonDerivative · entry 1 Tyree James L · CIK 0001324991 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,103 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 25, 2008 Filed Aug 27, 2008 21:09 UTC |
Schumacher Laura JExecutive Vice President
|
SaleCommon shares without par value | 5,114 | $57.95 | $296,332.78 |
DisclosureSEC source: 0001104659-08-055506 · a4.xml · nonDerivative · entry 2 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · Profit Sharing Trust Disclosed balance after: 0 F1 · shares: Balance in the Abbott Laboratories Stock Retirement Trust as of August 25, 2008. Read SEC document |
| August 20, 2008 Filed Aug 22, 2008 20:04 UTC |
Schumacher Laura JExecutive Vice President
|
GrantOption (right to buy) · Derivative | 1,055 | $0.00 Strike: $58.86 | $0.00 |
DisclosureSEC source: 0001104659-08-054645 · a4.xml · derivative · entry 8 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,055 Underlying: Common shares · 1,055 shares Expires 2010-02-10 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 20, 2008 Filed Aug 22, 2008 20:04 UTC |
Schumacher Laura JExecutive Vice President
|
GrantOption (right to buy) · Derivative | 7,340 | $0.00 Strike: $58.86 | $0.00 |
DisclosureSEC source: 0001104659-08-054645 · a4.xml · derivative · entry 7 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,340 Underlying: Common shares · 7,340 shares Expires 2011-02-08 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 20, 2008 Filed Aug 22, 2008 20:04 UTC |
Schumacher Laura JExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 1,213 | $0.00 Strike: $46.19 | $0.00 |
DisclosureSEC source: 0001104659-08-054645 · a4.xml · derivative · entry 6 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,475 Underlying: Common shares · 1,213 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 20, 2008 Filed Aug 22, 2008 20:04 UTC |
Schumacher Laura JExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 8,515 | $0.00 Strike: $45.45 | $0.00 |
DisclosureSEC source: 0001104659-08-054645 · a4.xml · derivative · entry 5 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 8,515 shares Expires 2011-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 20, 2008 Filed Aug 22, 2008 20:04 UTC |
Schumacher Laura JExecutive Vice President
|
Tax withholdingCommon shares without par value | 8,395 | $58.86 | $494,129.70 |
DisclosureSEC source: 0001104659-08-054645 · a4.xml · nonDerivative · entry 3 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,402 Read SEC document |
| August 20, 2008 Filed Aug 22, 2008 20:04 UTC |
Schumacher Laura JExecutive Vice President
|
Exercise / conversionCommon shares without par value | 1,213 | $46.19 | $56,028.47 |
DisclosureSEC source: 0001104659-08-054645 · a4.xml · nonDerivative · entry 2 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,797 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 20, 2008 Filed Aug 22, 2008 20:04 UTC |
Schumacher Laura JExecutive Vice President
|
Exercise / conversionCommon shares without par value | 8,515 | $45.45 | $386,996.53 |
DisclosureSEC source: 0001104659-08-054645 · a4.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,584 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 18, 2008 Filed Dec 31, 2008 22:01 UTC |
Hance Robert BSenior Vice President
|
GiftCommon shares without par value | 20 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-08-079128 · a4.xml · nonDerivative · entry 2 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,035 Read SEC document |
| August 18, 2008 Filed Dec 31, 2008 22:01 UTC |
Hance Robert BSenior Vice President
|
GiftCommon shares without par value | 20 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-08-079128 · a4.xml · nonDerivative · entry 1 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,055 Read SEC document |
| August 11, 2008 Filed Aug 13, 2008 21:15 UTC |
WHITE MILES DDirector · Chairman and CEO
|
GrantOption (right to buy) · Derivative | 178,002 | $0.00 Strike: $59.03 | $0.00 |
DisclosureSEC source: 0001104659-08-052650 · a4.xml · derivative · entry 7 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,002 Underlying: Common shares · 178,002 shares Expires 2013-02-13 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 11, 2008 Filed Aug 13, 2008 21:15 UTC |
WHITE MILES DDirector · Chairman and CEO
|
Exercise / conversionOption (right to buy) · Derivative | 202,822 | $0.00 Strike: $47.10 | $0.00 |
DisclosureSEC source: 0001104659-08-052650 · a4.xml · derivative · entry 6 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,956 Underlying: Common shares · 202,822 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 11, 2008 Filed Aug 13, 2008 21:15 UTC |
WHITE MILES DDirector · Chairman and CEO
|
Tax withholdingCommon shares without par value | 178,002 | $59.03 | $10,507,458.06 |
DisclosureSEC source: 0001104659-08-052650 · a4.xml · nonDerivative · entry 2 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,256,181 Read SEC document |
| August 11, 2008 Filed Aug 13, 2008 21:15 UTC |
WHITE MILES DDirector · Chairman and CEO
|
Exercise / conversionCommon shares without par value | 202,822 | $47.10 | $9,552,916.20 |
DisclosureSEC source: 0001104659-08-052650 · a4.xml · nonDerivative · entry 1 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,434,183 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 08, 2008 Filed Aug 12, 2008 23:50 UTC |
Chen Thomas FSenior Vice President
|
SaleCommon shares without par value | 2,772 | $59.00 | $163,548.00 |
DisclosureSEC source: 0001104659-08-052315 · a4.xml · nonDerivative · entry 8 Chen Thomas F · CIK 0001360147 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By daughter Disclosed balance after: 610 F2 · balance_after: The reporting person disclaims beneficial ownership of all securities held by his wife and daughter. Read SEC document |
| August 08, 2008 Filed Aug 12, 2008 23:50 UTC |
Chen Thomas FSenior Vice President
|
SaleCommon shares without par value | 7,228 | $59.00 | $426,452.00 |
DisclosureSEC source: 0001104659-08-052315 · a4.xml · nonDerivative · entry 1 Chen Thomas F · CIK 0001360147 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,568 Read SEC document |
| August 06, 2008 Filed Aug 8, 2008 21:16 UTC |
WHITE MILES DDirector · Chairman & CEO
|
Exercise / conversionOption (right to buy) · Derivative | 1 | $0.00 Strike: $40.56 | $0.00 |
DisclosureSEC source: 0001104659-08-051461 · a4.xml · derivative · entry 30 WHITE MILES D · CIK 0001239129 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 1 shares Expires 2008-09-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 06, 2008 Filed Aug 8, 2008 21:16 UTC |
WHITE MILES DDirector · Chairman & CEO
|
Exercise / conversionOption (right to buy) · Derivative | 92,521 | $0.00 Strike: $53.60 | $0.00 |
DisclosureSEC source: 0001104659-08-051461 · a4.xml · derivative · entry 29 WHITE MILES D · CIK 0001239129 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 92,521 shares Expires 2008-09-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 06, 2008 Filed Aug 8, 2008 21:16 UTC |
WHITE MILES DDirector · Chairman & CEO
|
Exercise / conversionOption (right to buy) · Derivative | 44,046 | $0.00 Strike: $52.55 | $0.00 |
DisclosureSEC source: 0001104659-08-051461 · a4.xml · derivative · entry 28 WHITE MILES D · CIK 0001239129 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 44,046 shares Expires 2008-09-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 06, 2008 Filed Aug 8, 2008 21:16 UTC |
WHITE MILES DDirector · Chairman & CEO
|
SaleCommon shares without par value | 300 | $58.85 | $17,655.00 |
DisclosureSEC source: 0001104659-08-051461 · a4.xml · nonDerivative · entry 24 WHITE MILES D · CIK 0001239129 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,231,361 Read SEC document |
| August 06, 2008 Filed Aug 8, 2008 21:16 UTC |
WHITE MILES DDirector · Chairman & CEO
|
SaleCommon shares without par value | 1,500 | $58.84 | $88,260.00 |
DisclosureSEC source: 0001104659-08-051461 · a4.xml · nonDerivative · entry 23 WHITE MILES D · CIK 0001239129 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,231,661 Read SEC document |
| August 06, 2008 Filed Aug 8, 2008 21:16 UTC |
WHITE MILES DDirector · Chairman & CEO
|
SaleCommon shares without par value | 500 | $58.83 | $29,415.00 |
DisclosureSEC source: 0001104659-08-051461 · a4.xml · nonDerivative · entry 22 WHITE MILES D · CIK 0001239129 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,233,161 Read SEC document |
| August 06, 2008 Filed Aug 8, 2008 21:16 UTC |
WHITE MILES DDirector · Chairman & CEO
|
SaleCommon shares without par value | 4,000 | $58.82 | $235,280.00 |
DisclosureSEC source: 0001104659-08-051461 · a4.xml · nonDerivative · entry 21 WHITE MILES D · CIK 0001239129 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,233,661 Read SEC document |
| August 06, 2008 Filed Aug 8, 2008 21:16 UTC |
WHITE MILES DDirector · Chairman & CEO
|
SaleCommon shares without par value | 2,100 | $58.81 | $123,501.00 |
DisclosureSEC source: 0001104659-08-051461 · a4.xml · nonDerivative · entry 20 WHITE MILES D · CIK 0001239129 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,237,661 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.